Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomised Control Trial Investigating the Efficacy of Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)

NCT03479190 is registered in ClinicalTrials.gov with Northumbria Healthcare NHS Foundation Trust as lead sponsor.

NCT NCT03479190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03479190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomised Control Trial Investigating the Efficacy of Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)
Lead sponsor
Northumbria Healthcare NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
September 3, 2018
Completion date
April 3, 2022
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

greater trochanteric pain syndrome